The Nanomedicines Alliance provides:

 

• Greater presence in nanotechnology-related scientific, business, and regulatory communities

 

• Increased opportunities for collaborative research, industry surveys, and benchmarking exercises

 

• Opportunities to present Alliance findings through peer-reviewed publications, scientific conferences, workshops, and roundtables

 

• Enhanced possibilities for external collaborations with government and regulatory authorities, other trade groups, and advocacy agencies

 

• Opportunities to define priority issues of science, regulation, and policy

 

• Sustained forum for exchange of ideas on nanomaterials and nanotechnologies